Lessons From TAVR For Medicare’s ‘Coverage With Evidence Development’ Program Pei-Jung Lin,Sean R. Tunis,andPeter J. Neumann June 11, 202

https://www.healthaffairs.org/content/forefront/lessons-tavr-medicare-s-coverage-evidence-development-program?utm_campaign=forefront&utm_medium=email&_hsenc=p2ANqtz-_SIKFTPf4MBkJ2kanRONZ0lXVGFZ7v0pClxGy0SQOslMQ5QTulC0UNVintU_NZLqEuR6r3VvKu_zjM6dZpJFOjsff3DQ&_hsmi=423554003&utm_source=hasu Policymakers should preserve the achievements of the Transcatheter Aortic Valve Replacement registry while recognizing that ongoing evidence generation does not require a permanent mandate.